Lung Cancer with COVID-19: Symptom and Imaging Analysis-A Dilemma of Managing Multiple Comorbidities
Published: 2022-05-02
Page: 33-39
Issue: 2022 - Volume 5 [Issue 1]
Tutul Chowdhury *
One Brooklyn Health, 1545 Atlantic Ave, Brooklyn, NY 11213, New York, USA.
Uma Datta Gupta
One Brooklyn Health, 1545 Atlantic Ave, Brooklyn, NY 11213, New York, USA.
Padmaja Deb Roy
One Brooklyn Health, 1545 Atlantic Ave, Brooklyn, NY 11213, New York, USA.
Urmi Das
Chittagong Medical College and Hospital, Chittagong, Bangladesh.
Prasenjit Sarker
Chittagong Medical College and Hospital, Chittagong, Bangladesh.
Khondokar N. Hassan
Bangladesh Medical College and Hospital, Dhaka, Bangladesh.
*Author to whom correspondence should be addressed.
Abstract
According to the World Health organization worldwide Covid -19 related infection is 500 million with 6 million deaths. However, Covid-19 cases and deaths has continued to decline since the end of March 2022, a 24% and 12% decline respectively [1]. The most common symptoms of COVID-19 patients are coughs, colds, fevers, flu-like symptoms, and severe pneumonia [2]. In addition, our patient presented with complications from his Co-morbidities, such as diabetes leading to diabetic foot and emphysematous osteomyelitis. The patient was diagnosed as COVID-Positive during his regular follow-up. Meanwhile, the patient developed respiratory symptoms with CT scan findings of presumptive lung cancer. It was a diagnostic dilemma to treat the current infections or treat the patient as having severe COVID-19 pneumonia. However, continuing antibiotics and planning for further workup on lung cancer were helpful in our case. Our follow-up parameters have monitored arterial blood gas, calcitonin level, and other inflammatory markers to exclude COVID-related causes. We present this case to establish the best possible treatment plan for symptomatic COVID patients with other extreme co-morbidities and respiratory symptoms.
Keywords: COVID pneumonia, lung cancer, lung mass, cavitation, lung biopsy